Literature DB >> 10555653

Brain morphometric analysis in neurofibromatosis 1.

F J DiMario1, G R Ramsby, J A Burleson.   

Abstract

RATIONALE AND
OBJECTIVES: To investigate the relationships between brain and skull base growth in patients with neurofibromatosis 1 (NF1) compared with healthy control subjects using brain magnetic resonance imaging (MRI) for morphometric analysis.
METHODS: Evaluated patients included children who underwent T1- and T2-weighted or dual-echo proton density axial and T1-weighted sagittal brain MRI from January 1, 1988, to December 31, 1995. Study subjects (n = 27) received a diagnosis of NF1 by accepted National Institutes of Health clinical criteria and were compared with an age- and sex-matched control group (n = 43). Twenty-four predetermined ventricular and brain parenchymal dimensions and area calculations were evaluated. Data were analyzed using 2-tailed t tests, chi2 analysis, analysis of variance, and analysis of covariance adjusted for age and sex. Correlational analyses with respect to subject type and age were performed separately.
RESULTS: There were 27 patients (20 boys, aged 1.0-17.7 years; mean age, 8.8 years) and 43 controls (22 boys, aged 0.1-17.7 years; mean age, 5.9 years). The mean ages between groups (boys, girls, and totals) were not statistically different. Significant differences were appreciated for 6 of 24 measures. Patients with NF1 had a significantly larger bicaudate width (P = .002), biatrial width (P<.001), and biparietal diameter (P = .003), but not hemispheric length. They also had significantly increased iter measures (P = .004), descending sigmoid sinus (P<.001), and an age-specific increase in brainstem height (P = .03) not seen in controls.
CONCLUSIONS: Patients with NF1 experience dynamic changes in brain morphometry, resulting in a predominant lateral volume expansion of the supratentorial compartment and an increasing velocity of brainstem growth as they age. These data underscore brain-region-specific parenchymal overgrowth potential.

Entities:  

Mesh:

Year:  1999        PMID: 10555653     DOI: 10.1001/archneur.56.11.1343

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

2.  Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.

Authors:  Robert A Avery; Awais Mansoor; Rabia Idrees; Elijah Biggs; Mohammad Ali Alsharid; Roger J Packer; Marius George Linguraru
Journal:  Neurology       Date:  2016-05-11       Impact factor: 9.910

3.  Patterns of associations of clinical features in neurofibromatosis 1 (NF1).

Authors:  Jacek Szudek; D Gareth Evans; Jan M Friedman
Journal:  Hum Genet       Date:  2002-12-20       Impact factor: 4.132

4.  Mutations in MAST1 Cause Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical Malformations.

Authors:  Ratna Tripathy; Ines Leca; Tessa van Dijk; Janneke Weiss; Bregje W van Bon; Maria Christina Sergaki; Thomas Gstrein; Martin Breuss; Guoling Tian; Nadia Bahi-Buisson; Alexander R Paciorkowski; Alistair T Pagnamenta; Andrea Wenninger-Weinzierl; Maria Fernanda Martinez-Reza; Lukas Landler; Stefano Lise; Jenny C Taylor; Gaetano Terrone; Giuseppina Vitiello; Ennio Del Giudice; Nicola Brunetti-Pierri; Alessandra D'Amico; Alexandre Reymond; Norine Voisin; Jonathan A Bernstein; Ellyn Farrelly; Usha Kini; Thomas A Leonard; Stéphanie Valence; Lydie Burglen; Linlea Armstrong; Susan M Hiatt; Gregory M Cooper; Kimberly A Aldinger; William B Dobyns; Ghayda Mirzaa; Tyler Mark Pierson; Frank Baas; Jamel Chelly; Nicholas J Cowan; David Anthony Keays
Journal:  Neuron       Date:  2018-11-15       Impact factor: 17.173

Review 5.  Diagnosis and management of neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Curr Neurol Neurosci Rep       Date:  2001-03       Impact factor: 6.030

6.  Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities.

Authors:  Inês R Violante; Maria J Ribeiro; Eduardo D Silva; Miguel Castelo-Branco
Journal:  J Neurodev Disord       Date:  2013-02-13       Impact factor: 4.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.